-
Nan Fang Yi Ke Da Xue Xue Bao · Oct 2012
Randomized Controlled Trial[Effect of ulinastatin for hepatoprotection following extracorporeal membrane oxygenation].
- Binfei Li, Xiaozu Liao, Zhou Cheng, and Zhigang Zhang.
- Department of Anesthesiology, Zhongshan People's Hospital, Zhongshan, China. lbf8@msn.com
- Nan Fang Yi Ke Da Xue Xue Bao. 2012 Oct 1; 32 (10): 1511-2.
ObjectiveTo explore the effect of ulinastatin in hepatoprotection following extracorporeal membrane oxygenation (ECMO).MethodsForty patients with ECMO were randomized into two groups to receive ulinastatin treatment or not. Venous blood samples were collected to test ALT and AST levels following ECMO treatment for 12, 24 and 48 h.ResultsThe two groups showed no significant difference in liver function indices before ECMO treatment. In both groups, the liver function worsened significantly after a 12-h ECMO treatment, but improved gradually after 24 h. The liver function damages were obviously lessened in ulinastatin group compared to those in patients without ulinastatin treatment (P<0.05). ECMO treatment significantly improved the liver function of the patients.ConclusionECMO can significantly improve the liver function. The liver function damage reaches the peak level after a 12-h ECMO treatment, and ulinastatin can protect the liver function in patients undergoing ECMO.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..